Medicare IVIG Demonstration Extension Act of 2017

Bill: 115-hr-3172
Sponsor: full_name: Rep. Brady, Kevin [R-TX-8]
Introduced: 2017-07-10
Policy area: Health
Subjects: Drug therapy

Health technology, devices, supplies

Home and outpatient care

Immunology and vaccination

Medicare
Latest action: action_date: 2017-07-20
text: Referred to the Subcommittee on Health.

Summaries:
action_date: 2017-07-10
action_desc: Introduced in House
text: <p><strong>Medicare&nbsp;IVIG Demonstration Extension Act of 2017</strong></p> <p>This bill amends the Medicare IVIG Access and Strengthening Medicare and Repaying Taxpayers Act of 2012 to&nbsp;extend the Medicare Intravenous Immune Globulin (IVIG) demonstration project through 2020, subject to the availability of funds. (This demonstration project provides for bundled Medicare payments with respect to certain items and services that are necessary to administer IVIG in the home.)&nbsp;A&nbsp;Medicare beneficiary who is enrolled in the project on September 30, 2017, shall be automatically reenrolled, subject to an existing cap on project participants.</p>

tv_txt: I 115th CONGRESS 1st Session H. R. 3172 IN THE HOUSE OF REPRESENTATIVES July 10, 2017 Mr. Brady of Texas (for himself and Ms. Matsui ) introduced the following bill; which was referred to the Committee on Energy and Commerce , and in addition to the Committee on Ways and Means , for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned A BILL To amend the Medicare IVIG Access and Strengthening Medicare and Repaying Taxpayers Act of 2012 to extend the Medicare Patient IVIG Access Demonstration Project.

1. Short title This Act may be cited as the Medicare IVIG Demonstration Extension Act of 2017 . 2. Extension of Medicare Patient IVIG Access Demonstration Project Section 101(b) of the Medicare IVIG Access and Strengthening Medicare and Repaying Taxpayers Act of 2012 ( 42 U.S.C. 1395l note) is amended— (1) in paragraph (1), by inserting after for a period of 3 years the following: and, subject to the availability of funds under subsection (g)— (A) if the date of enactment of the Medicare IVIG Demonstration Extension Act of 2017 is on or before September 30, 2017, for the period beginning on October 1, 2017, and ending on December 31, 2020; and (B) if the date of enactment of such Act is after September 30, 2017, for the period beginning on the date of enactment of such Act and ending on December 31, 2020 ; and (2) in paragraph (2), by adding at the end the following new sentence: Subject to the preceding sentence, a Medicare beneficiary enrolled in the demonstration project on September 30, 2017, shall be automatically enrolled during the period beginning on the date of the enactment of the Medicare IVIG Demonstration Extension Act of 2017 and ending on December 31, 2020, without submission of another application. .